-
Opioid drugmaker Insys Therapeutics files for bankruptcy
10 Jun 2019 11:12 GMT
(Reuters) - Drugmaker Insys Therapeutics Inc filed for Chapter 11 … Kapoor, the billionaire founder of Insys Therapeutics Inc, leaves the federal courthouse … what became the best-performing initial public offering of that year.
The Justice …
-
INSYS Therapeutics Implements Leadership Changes
15 Apr 2019 12:30 GMT
… 15, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader … leading up to Patheon’s IPO. Prior to working at Patheon …
-
McCaskill Opioid Investigation Releases First Report Detailing Systemic Manipulation of Prior Authorization Process by Insys Therapeutics
06 Sep 2017 21:45 GMT
… distributors. "Fueling an Epidemic: Insys Therapeutics and the Systemic Manipulation of … " describes the emphasis Insys Therapeutics put on boosting approvals for … had "the best-performing initial public offering in 2013," and, over …
-
INSYS Therapeutics Hires First Corporate Communications Leader and New Investor Relations Agency
21 Sep 2017 20:01 GMT
… 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) … About INSYS
Insys Therapeutics is a specialty pharmaceutical … measurement, perception studies, IPOs, transaction and crises … , Corporate Communications
INSYS Therapeutics
480-500-3101 …
-
Insys Therapeutics, Inc. Appoints Andrew G. Long as Chief Financial Officer
18 Jul 2017 10:50 GMT
… leading up to Patheon’s IPO. Prior to his role … CFO since the Company’s IPO in 2013, for his … added Motahari. About INSYS
Insys Therapeutics is a specialty pharmaceutical company … , Inc., a subsidiary of Insys Therapeutics, Inc. Forward-Looking Statements …
-
BRIEF-Insys Therapeutics appoints Andrew Long as chief financial officer
18 Jul 2017 11:28 GMT
July 18 (Reuters) - Insys Therapeutics Inc:
* Insys Therapeutics, Inc appoints Andrew G … G. Long appointed cfo
* Insys Therapeutics Inc - long most … 2015 to 2017
* Insys Therapeutics Inc - Andrew Long replaces … since company's IPO in 2013 Source text …
-
Insys Therapeutics : Announces Chief Financial Officer Transition
26 May 2017 20:17 GMT
… 16, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) (… evolution from a pre-IPO startup to a NASDAQ … .'
About Insys
Insys Therapeutics is a specialty pharmaceutical … Inc., a subsidiary of Insys Therapeutics, Inc.
Forward-Looking Statements …
-
Insys Therapeutics Announces Chief Financial Officer Transition
16 May 2017 10:55 GMT
… ;s evolution from a pre-IPO startup to a NASDAQ-listed … pipeline candidates." About Insys
Insys Therapeutics is a specialty pharmaceutical company … Company, Inc., a subsidiary of Insys Therapeutics, Inc. Forward-Looking StatementsThis press …
-
Insys Therapeutics Announces Chief Financial Officer Transition
16 May 2017 10:50 GMT
… , 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) … evolution from a pre-IPO startup to a … candidates." About Insys
Insys Therapeutics is a specialty pharmaceutical … Inc., a subsidiary of Insys Therapeutics, Inc. Forward-Looking Statements …
About
© 1995-2025